Akute Bronchitis Therapie: Akute Bronchitis Therapie
Most people with chronic bronchitis have chronic obstructive pulmonary disease (COPD). With numerous other factors for example air pollution and genetics playing a smaller role, tobacco smoking is the most common cause. Symptoms of chronic bronchitis may include wheezing and shortness of breath, especially upon exertion and low oxygen saturations. Smoking cigarettes or other kinds of tobacco cause most cases of chronic bronchitis. Additionally, continual inhalation of air pollution or irritating fumes or dust from hazardous exposures in vocations such as grain handling, coal mining, textile production, livestock farming, and metal moulding can also be a risk factor for the development of chronic bronchitis. Unlike other common obstructive ailments for example asthma or emphysema, bronchitis infrequently causes a high residual volume (the volume of air remaining in the lungs after a maximal exhalation attempt).
On the other hand, the coughs due to bronchitis can continue for around three weeks or more even after all other symptoms have subsided. Acute bronchitis shouldn't be treated with antibiotics unless microscopic examination of the sputum shows large numbers of bacteria. Acute bronchitis generally lasts weeks or a couple of days. Should the cough last longer than the usual month, some physicians may issue a referral to an otorhinolaryngologist (ear, nose and throat doctor) to see if your state besides bronchitis is causing the irritation.
- Bronchitis is typically described as what common affliction?
- Take this quiz to comprehend the primary types of bronchitis, why and who gets it.
Dabei handelt es sich um eine hochwirksame Behandlung, welche die Atemwege (Mund, Nase, Nebenhöhlen, Luftröhre, Bronchien) und teilweise auch die ...
Bronchitis Treatment & Management Medscape Reference
Based on 2006 American College of Chest Physicians (ACCP) guidelines, central cough suppressants such as codeine and dextromethorphan are recommended for short-term symptomatic relief of coughing in patients with acute and chronic bronchitis. Also based on 2006 ACCP guidelines, treatment with short-acting beta-agonists ipratropium bromide and theophylline may be used to control symptoms like bronchospasm, dyspnea, and persistent cough in stable patients with chronic bronchitis. For patients having an acute exacerbation of chronic bronchitis, therapy with short-acting agonists or anticholinergic bronchodilators should be administered during the acute exacerbation. In acute bronchitis, treatment with beta2-agonist bronchodilators may be useful in patients who have connected wheezing with cough and underlying lung disorder. In patients with chronic bronchitis or chronic obstructive pulmonary disease (COPD), treatment with mucolytics has been correlated with a modest reduction in acute exacerbations and a decrease in the total number of days of incapacity.